ESTA Valuation

Establishment Labs Holdings Inc

Add to Watchlist

Advanced Chart

64.910

+4.4(7.272%)1D

ESTA Relative Valuation

ESTA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ESTA is overvalued; if below, it's undervalued.

Historical Valuation

Establishment Labs Holdings Inc (ESTA) is now in the Overvalued zone, suggesting that its current forward PS ratio of 60.51 is considered Overvalued compared with the five-year average of -32.12. The fair price of Establishment Labs Holdings Inc (ESTA) is between 9.85 to 16.88 according to relative valuation methord. Compared to the current price of 60.51 USD , Establishment Labs Holdings Inc is Overvalued By 258.39%.

Relative Value

Fair Zone

9.85-16.88

Current Price：60.51

258.39%

Overvalued

-37.20

Trailing

Forward

-357.61

EV/EBITDA

Establishment Labs Holdings Inc. (ESTA) has a current EV/EBITDA of -357.61. The 5-year average EV/EBITDA is -106.31. The thresholds are as follows: Strongly Undervalued below -310.28, Undervalued between -310.28 and -208.30, Fairly Valued between -4.32 and -208.30, Overvalued between -4.32 and 97.67, and Strongly Overvalued above 97.67. The current Forward EV/EBITDA of -357.61 falls within the Strongly Undervalued range.

-52.78

EV/EBIT

Establishment Labs Holdings Inc. (ESTA) has a current EV/EBIT of -52.78. The 5-year average EV/EBIT is -48.91. The thresholds are as follows: Strongly Undervalued below -94.79, Undervalued between -94.79 and -71.85, Fairly Valued between -25.97 and -71.85, Overvalued between -25.97 and -3.03, and Strongly Overvalued above -3.03. The current Forward EV/EBIT of -52.78 falls within the Historic Trend Line -Fairly Valued range.

60.51

Establishment Labs Holdings Inc. (ESTA) has a current PS of 60.51. The 5-year average PS is 8.24. The thresholds are as follows: Strongly Undervalued below -0.55, Undervalued between -0.55 and 3.84, Fairly Valued between 12.63 and 3.84, Overvalued between 12.63 and 17.03, and Strongly Overvalued above 17.03. The current Forward PS of 60.51 falls within the Strongly Overvalued range.

-92.32

P/OCF

Establishment Labs Holdings Inc. (ESTA) has a current P/OCF of -92.32. The 5-year average P/OCF is -29.56. The thresholds are as follows: Strongly Undervalued below -72.20, Undervalued between -72.20 and -50.88, Fairly Valued between -8.25 and -50.88, Overvalued between -8.25 and 13.07, and Strongly Overvalued above 13.07. The current Forward P/OCF of -92.32 falls within the Strongly Undervalued range.

-125.89

P/FCF

Establishment Labs Holdings Inc. (ESTA) has a current P/FCF of -125.89. The 5-year average P/FCF is -46.54. The thresholds are as follows: Strongly Undervalued below -187.88, Undervalued between -187.88 and -117.21, Fairly Valued between 24.14 and -117.21, Overvalued between 24.14 and 94.81, and Strongly Overvalued above 94.81. The current Forward P/FCF of -125.89 falls within the Undervalued range.

Establishment Labs Holdings Inc (ESTA) has a current Price-to-Book (P/B) ratio of 77.01. Compared to its 3-year average P/B ratio of 52.93 , the current P/B ratio is approximately 45.50% higher. Relative to its 5-year average P/B ratio of 62.82, the current P/B ratio is about 22.58% higher. Establishment Labs Holdings Inc (ESTA) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -7.55%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -5.35% , the current FCF yield is about -100.00% lower.

77.01

P/B

Median3y

52.93

Median5y

62.82

-5.58

FCF Yield

Median3y

-7.55

Median5y

-5.35

Competitors Valuation Multiple

The average P/S ratio for ESTA's competitors is 29.47, providing a benchmark for relative valuation. Establishment Labs Holdings Inc Corp (ESTA) exhibits a P/S ratio of 60.51, which is 105.30% above the industry average. Given its robust revenue growth of 33.70%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

ESTA.O

Establishment Labs Holdings Inc

Kestra Medical Technologies Ltd

BioLife Solutions Inc

27.57

28.94%

1.29B

Performance Decomposition

Market capitalization of ESTA increased by 31.86% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -13.27 to -19.66.

The secondary factor is the Revenue Growth, contributed 33.70%to the performance.

Overall, the performance of ESTA in the past 1 year is driven by P/E Change. Which is more unsustainable.

33.70%

40.23M → 53.78M

Revenue Growth

-50.04%

-41.47 → -20.72

Margin Expansion

48.20%

-13.27 → -19.66

P/E Change

31.86%